reason report
disappoint guidanc clear event robust
pipelin pt
top bottom-lin though result disappoint
deliv second highest book quarter histori
revenu quarter miss expect due miss low
margin tech-resal slowdown licens softwar though
revenu quarter disappoint sound like robust
pipelin va dod continu progress well continu
see strong demand domest intern market
revenu guid grow y/i midpoint
slightli behind assum consensu midpoint ep
guidanc behind consensu due higher tax rate
assumpt margin expans estim gener
disappoint quarter view expect top-lin growth rate
decent guid like view clear event
remain posit given solid pipelin abil capit
continu hospit support va dod deal
reduc pt
disappoint result adjust ep roughli in-
line svb leerink/consensu howev qualiti
meet rel model low due part one-tim
adjust total revenu trail svb leerink/consensu
contribut lower-than-expect adjust
oper incom vs svb leerink/consensu
revenu trail manag guidanc
due primarili lower-than-expect technolog re-sal revenu
y/i manag suggest signific declin
technolog re-sal revenu result time softwar sale
continu affect transit saa ultim lead
reduc volatil quarter disappoint encourag
growth profession manag servic
expect rang
bracket prior svb leerink/consensu adj
ep expect rang behind prior svb
leerink/consensu book expect
 y/i behind prior estim
manag expect revenu
 vs prior svb leerink/consensu adj
ep guid rang behind prior
svb leerink/consensu
net debt total capit
price-to-earnings lt ep growth
ep
year price history/av daili volume mil
compani inform svb leerink llc research
revenu mm
pleas refer page import disclosur price chart analyst certif
manag suggest attract marketplac manag
highlight strong pipelin near record level good
key growth area work revenu cycl popul
health y/i thirty-eight percent contract long term
compar previou period
outsid base consist sequenti contract
quarter highlight expans
new footprint like deal lumeri although manag
previous state still take year gener
meaning revenu partnership encourag hear
joint go-liv long term healtheint custom also
encourag comment regard posit benefit
larg client drive consolid
govern intern highlight
dod compani second wave site
implement plan progress va also on-plan
track ramp throughout year first mileston go-liv
addit task order sign va
steadi ramp work continu estim within year
va could gener annual revenu though take time
get run-rat outsid growth quarter
flat y/i howev year second competit region
win sweden top competitor expect epic
brent shafer first year ceo come end dividend
announc new ceo brent shafer reflect first year
introduc initi quarterli dividend
aim illustr confid commit
manag team went highlight intent work grow
dividend time increas stock appeal wider base
previous shafer highlight want advanc client
success implement intellig network creat better outcom
partner choic led belief senior leadership
aggress enough gener new revenu sourc
entiti lumeri continu think sinc beyond
meaning use creat evol like asset sentiment
revenu earn would improv significantli
tweak estim introduct guid
releas result updat model lower
ep revenu estim quarter
behind estim remain encourag larg backlog
visibl continu progress va dod deal
continu believ one best hcit platform
world book like declin y/i due sever larg longer
term deal book howev still think demand
remain robust maintain op rate price declin
lead develop market clinic financi inform technolog
solut healthcar compani solut larg hospit integr deliveri
network serv hospit market ambulatori segment offer
affili physician practic believ well posit clinic technolog vendor
benefit hcit spend next year compani larg reference-
custom base broad product offer addit compani gener
revenu outsid presenc europ middl east asia believ
replac market opportun robust continu win share
intern market believ signific opportun expand
revwork itwork offer market slow believ
continu win share due activ firm patient account solut improv
significantli compani consist report steadi growth va deal larg win
also expect popul health manag busi grow robust pace
result rate share outperform
share trade ep compani
averag gener posit given improv revenu
cycl patient account solut good growth across cern busi segment
includ communitywork revenu cycl popul health manag core
sale believ hospit activ continu idn stand benefit like
lumeri transact gener posit cern long-term outlook therefor
next month expect share trade ep
impli price target believ qualiti product well
publicli trade hcit peer believ long-term outlook hcit favor
result rate share outperform
time book sale earn hard predict hcit
compani tend long sale implement cycl new busi book lead
indic futur revenu earn growth lumpi hard predict
lumpi provid inher lack visibl exact time revenu earn
recognit lead volatil share investor expect execut
hard predict histor stock signific short interest limit
public float compani share held would character
long-term patient investor factor trade sharesespeci
around report seasoncan somewhat volatil share price perform difficult
predict errat share movement could pose risk sharehold
oper expens revenue
rev
transact push miss
ahead model
ahead model
ahead model
behind larg miss tech resal licens softwar
wors expect higher sale client servic
softwar develop partial off-set lower
slightli lower model
behind due revenu shortfal increas opex
top-lin opex miss drive op incom miss
wors expect headwind adj ep
compani report svb leerink llc estim
top-lin miss higher opex high tax rate contribut miss
dollar million
rev
rev
rev
rev
rev
rev
compani report svb leerink llc estim
dollar million
contract new client
contract long-term contract
contract incl
estim price
revenu includ book
book
high end book guidanc
compani report svb leerink llc estim
